Hbm Healthcare Investments (Cayman) Ltd. is > 10% Shareholder of IO Biotech, Inc.. Currently has a direct ownership of 2.69 Million shares of IOBT, which is worth approximately $3.17 Million. The most recent transaction as insider was on Nov 09, 2021, when has been sold 325,000 shares (Common Stock) at a price of $14.0 per share, resulting in proceeds of $4,550,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.69M
0% 3M change
0% 12M change
Total Value Held $3.17 Million

HBM Healthcare Investments (Cayman) Ltd. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 09 2021
BUY
Open market or private purchase
$4,550,000 $14.0 p/Share
325,000 Added 10.78%
2,690,545 Common Stock
Nov 09 2021
BUY
Conversion of derivative security
-
2,365,545 Added 50.0%
2,365,545 Common Stock

Also insider at

HOWL
Werewolf Therapeutics, Inc. Healthcare
MLYS
Mineralys Therapeutics, Inc.
HHI

Hbm Healthcare Investments (Cayman) Ltd.

> 10% Shareholder
Grand Cayman, E9

Track Institutional and Insider Activities on IOBT

Follow IO Biotech, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IOBT shares.

Notify only if

Insider Trading

Get notified when an Io Biotech, Inc. insider buys or sells IOBT shares.

Notify only if

News

Receive news related to IO Biotech, Inc.

Track Activities on IOBT